The moment a man is told that no sperm were found in his semen sample — that he has azoospermia — is one of the most difficult moments in a couple's fertility journey. The word itself feels final. The absence of sperm seems, at first hearing, to close the door on biological fatherhood entirely.
It does not — in many cases. And the purpose of this article is to explain precisely why, and under what circumstances, azoospermia can be successfully treated.
Azoospermia is not a single condition. It is a clinical finding — the absence of sperm in the ejaculate — that arises from two fundamentally different underlying causes, each with its own mechanism, its own investigation pathway, and its own treatment approach. Understanding which type of azoospermia a man has is the most important clinical determination — because it determines whether sperm can be retrieved from elsewhere in the reproductive system, what the probability of finding sperm is, and what the pathway to biological fatherhood looks like.
For men with one type of azoospermia, sperm retrieval is achievable in the vast majority of cases. For men with the other type, it is achievable in a substantial proportion of carefully assessed cases. In both situations, the conclusion that biological fatherhood is impossible should never be reached without the comprehensive evaluation and surgical assessment that determines what is actually possible.
What Is Azoospermia?
Azoospermia is defined as the complete absence of sperm in the ejaculate — no sperm found on microscopic examination of the centrifuged semen sample, confirmed on at least two separate occasions.
It affects approximately 1 percent of all men and approximately 10 to 15 percent of men presenting with infertility. Despite being the most severe form of male factor infertility — because it means that natural conception and IUI are not possible — it is not synonymous with hopeless infertility.
The crucial distinction is between the two main types of azoospermia.
Obstructive Azoospermia — The Blocked Pathway
Obstructive azoospermia (OA) is a condition in which sperm production in the testes is normal or near-normal, but a blockage somewhere along the reproductive tract prevents sperm from reaching the ejaculate.
The sperm are being produced. They simply cannot get out.
The blockage can occur at several anatomical locations.
The epididymis — the coiled tube where sperm mature and are stored — can become blocked by infection, by previous scrotal trauma, or by congenital abnormality. Epididymal blockage is one of the most common causes of obstructive azoospermia in India, where a history of genitourinary infection or epididymo-orchitis is relatively common.
The vas deferens — the tube that carries sperm from the epididymis to the ejaculatory ducts — can be blocked by previous vasectomy, by inguinal hernia surgery that inadvertently damaged the vas, or by congenital bilateral absence of the vas deferens (CBAVD). CBAVD — in which the vas deferens is absent from birth — is closely associated with cystic fibrosis gene mutations (CFTR mutations) and is found in approximately 1 to 2 percent of infertile men.
The ejaculatory ducts — the final section of the sperm transport pathway — can be obstructed by cysts, inflammatory scarring, or calcification.
The clinical characteristics that distinguish obstructive from non-obstructive azoospermia are important. In obstructive azoospermia, the testes are typically of normal size — because testicular function (including testosterone production) is normal — and the FSH level is typically normal or only mildly elevated — because the pituitary does not need to work harder to stimulate adequately functioning testes. The epididymis may be palpably full or dilated on physical examination, suggesting that sperm are accumulating proximal to the blockage.
Treatment of Obstructive Azoospermia
For men with obstructive azoospermia, sperm are present in the testes and epididymis — they simply cannot reach the ejaculate. The treatment involves retrieving sperm from the location where they are present and using them for IVF with ICSI.
PESA — Percutaneous Epididymal Sperm Aspiration is the simplest retrieval technique and the first approach for obstructive azoospermia. A fine needle is passed through the scrotal skin into the epididymis under local anaesthesia or light sedation. Gentle aspiration draws epididymal fluid — rich in stored sperm — into the collection syringe. The fluid is immediately assessed by the embryologist, and motile sperm are identified and prepared for ICSI.
PESA is performed in the same session as the female partner's egg retrieval, so that fresh sperm can be used for fertilization on the same day. If the retrieved sperm are present in sufficient numbers, the excess can be cryopreserved for future cycles.
Success rates for sperm retrieval in obstructive azoospermia through PESA are very high — motile sperm are found in the majority of cases, particularly when the obstruction is in the epididymis and testicular function is normal.
TESA — Testicular Sperm Aspiration — involves aspirating sperm directly from the testicular tissue through a needle, when epididymal aspiration has not yielded adequate sperm. In obstructive azoospermia, testicular tissue contains abundant sperm in the seminiferous tubules, and TESA typically retrieves adequate sperm for ICSI.
Surgical reconstruction — vasectomy reversal or epididymovasostomy — is an alternative to sperm retrieval for selected men with obstructive azoospermia. Vasectomy reversal — reconnecting the vas deferens — can restore sperm to the ejaculate if performed within ten years of the vasectomy, with success rates declining significantly with longer intervals. Epididymovasostomy — bypassing an epididymal obstruction by connecting the vas deferens directly to the epididymis proximal to the blockage — is a more technically demanding procedure with variable success rates.
For many couples, sperm retrieval combined with IVF/ICSI is more efficient and more certain than surgical reconstruction — particularly when the female partner's fertility investigation also indicates that IVF will be needed regardless of whether the male factor is resolved. The decision between surgical reconstruction and sperm retrieval for IVF is individualized based on the type and location of the obstruction, the female partner's fertility, and the couple's goals.
Non-Obstructive Azoospermia — Impaired Sperm Production
Non-obstructive azoospermia (NOA) is a condition in which azoospermia results not from a blockage but from impaired sperm production within the testes themselves. The absence of sperm in the ejaculate reflects an absence or severe deficiency of sperm production — not a failure of transport.
NOA is clinically more challenging than obstructive azoospermia — because there is no blocked pathway to bypass. The sperm are simply not being produced, or are being produced in such small quantities or in such isolated focal areas within the testis that they do not reach the ejaculate.
The causes of non-obstructive azoospermia are diverse.
Klinefelter syndrome (47,XXY) — the most common genetic cause, in which the extra X chromosome causes testicular dysgenesis and impaired spermatogenesis. As described in our article on male infertility success stories, a proportion of Klinefelter syndrome patients have focal areas of spermatogenesis within the testes that can be retrieved by micro-TESE.
Y chromosome microdeletions — deletions in specific regions of the Y chromosome (AZF regions) that carry genes essential for spermatogenesis. AZFc deletions carry the highest probability of finding sperm at surgical retrieval. AZFa and AZFb deletions are associated with complete absence of spermatogenesis, and sperm retrieval is rarely successful.
Cryptorchidism (undescended testes) — even after surgical correction in childhood, men with a history of bilateral undescended testes may have impaired spermatogenesis due to the damage caused by the abnormal testicular temperature before correction.
Previous mumps orchitis — viral orchitis after puberty can permanently damage testicular tissue and impair spermatogenesis.
Previous chemotherapy or radiotherapy — cytotoxic cancer treatments can severely damage spermatogenic tissue.
Idiopathive NOA — in which no specific cause is identified despite thorough investigation — is one of the most common diagnoses, reflecting the limits of current diagnostic capability rather than the absence of a biological cause.
Sertoli-cell-only syndrome — in which the seminiferous tubules contain only Sertoli cells (the supporting cells) but no germ cells (the sperm-producing cells) — is associated with severely impaired or absent spermatogenesis.
The clinical characteristics of non-obstructive azoospermia typically include smaller testicular volume — because the reduced spermatogenic activity is associated with reduced tubular mass — and elevated FSH — because the pituitary increases FSH output in an attempt to stimulate inadequately functioning testes.
The Investigation Before Surgical Retrieval for NOA
Before surgical sperm retrieval is attempted for non-obstructive azoospermia, a specific and thorough investigation is essential — both to characterize the cause and to assess the probability of finding sperm at surgery.
Hormonal assessment — FSH, LH, testosterone, and prolactin — provides information about the degree of testicular dysfunction. Very high FSH with small testes is consistent with severe spermatogenic failure. Normal testosterone with high FSH reflects adequate Leydig cell (testosterone-producing) function with impaired tubular function.
Karyotype — chromosomal analysis of a blood sample — identifies Klinefelter syndrome (47,XXY) and other chromosomal abnormalities affecting fertility.
Y chromosome microdeletion analysis — identifies deletions in the AZFa, AZFb, and AZFc regions of the Y chromosome. As noted above, AZFa and AZFb deletions are associated with very low probability of sperm retrieval, and couples should be informed of this before surgical retrieval is attempted.
Scrotal ultrasound — assesses testicular volume, echogenicity, and any structural features that might provide prognostic information.
Genetic counseling — for couples where genetic testing identifies a heritable cause of NOA, genetic counseling is recommended before proceeding with surgical sperm retrieval and IVF/ICSI, to discuss the possibility that male offspring may inherit the same condition.
Surgical Sperm Retrieval for NOA — TESA and Micro-TESE
The key clinical insight about non-obstructive azoospermia is that even when sperm production is globally impaired, focal areas of residual spermatogenesis may persist within small regions of the testicular tissue. Sperm cannot be found in the ejaculate because the overall sperm production is too low — but within the testis, isolated tubules may be producing sperm in quantities sufficient for IVF/ICSI if those specific tubules can be identified and sampled.
TESA — standard testicular sperm aspiration — samples testicular tissue through needle aspiration at one or two sites. In non-obstructive azoospermia, sperm retrieval rates with standard TESA are approximately 20 to 30 percent — reflecting the random sampling of testicular tissue that may or may not coincide with focal spermatogenic activity.
Micro-TESE — Microsurgical Testicular Sperm Extraction — is the most effective surgical approach for non-obstructive azoospermia. Under an operating microscope providing magnification of twenty-five times or more, the testicular tissue is systematically examined for tubules that are larger, more opaque, and more likely to contain active spermatogenesis — characteristics that distinguish spermatogenically active tubules from inactive ones under high magnification. These selected tubules are excised and immediately examined by the embryologist for the presence of sperm.
Micro-TESE retrieval rates in non-obstructive azoospermia are approximately 40 to 60 percent in appropriately selected patients — significantly higher than standard TESA. For men with Klinefelter syndrome, micro-TESE retrieval rates are approximately 50 percent. For men with AZFc microdeletions, retrieval rates are approximately 70 percent. For men with AZFa or AZFb microdeletions or Sertoli-cell-only syndrome on testicular biopsy, retrieval rates are low — below 10 to 15 percent — and couples should be counseled realistically about this before surgery.
The sperm retrieved through micro-TESE are used for ICSI in an IVF cycle. Because the numbers are typically small, all retrieved sperm that are not immediately used should be cryopreserved for potential future cycles.
The Role of Medical Treatment Before Sperm Retrieval
For selected men with non-obstructive azoospermia, medical treatment before surgical retrieval may improve the probability of finding sperm.
Hormonal optimization — in men with low testosterone — using hCG injections or testosterone precursors may improve the intratesticular testosterone environment that supports spermatogenesis. Some studies have shown improved sperm retrieval rates in NOA patients pre-treated with hormonal optimization for three to six months.
Antioxidant therapy — reducing oxidative stress that impairs residual spermatogenesis — is rational and low-risk, and is recommended for most NOA patients in the months before surgical retrieval.
Treatment of hyperprolactinemia — when elevated prolactin is contributing to the hormonal disruption of spermatogenesis — with dopamine agonists before retrieval may improve outcomes.
What Happens When No Sperm Are Found at Retrieval
For men with non-obstructive azoospermia in whom surgical retrieval — even micro-TESE — does not yield sperm, the clinical conversation must address the realistic alternatives.
Donor sperm IVF or IUI — using sperm from an anonymous donor to fertilize the female partner's eggs — allows the female partner to experience pregnancy and childbirth and produces a child genetically related to her. Under the ART Regulation Act 2021 in India, donor sperm use is regulated, and the process is conducted through registered sperm banks.
Adoption — provides a path to parenthood that is not biologically related to either partner but is no less meaningful for that.
At Metro IVF, these conversations are conducted with full honesty, complete respect for the couple's autonomy, and without any minimization of the emotional weight of the clinical conclusion that biological fatherhood through the male partner's own sperm is not achievable. The couple's decisions about what comes next belong to them — the clinical team's role is to provide the most complete and honest information available on which those decisions can be based.
The Most Important Message
The most important message of this article is the same as the most important message of our earlier article on zero sperm count and TESA/PESA: a diagnosis of azoospermia is not a verdict. It is the beginning of an investigation.
An investigation that must include the distinction between obstructive and non-obstructive azoospermia. That must include hormonal assessment, genetic testing, and physical examination. That must, where indicated, include surgical retrieval — performed by a specialist with the training, equipment, and laboratory support to give the procedure the best possible chance of finding sperm.
At Metro IVF in Ambikapur, Dr. Ashish Soni conducts this investigation for every man with azoospermia — thoroughly, honestly, and with the specific expertise that finding sperm where they exist, and knowing when they cannot be found, requires.
Your Next Step
If you or your partner has been told no sperm were found in the semen — either for the first time or after being told nothing more can be done at another clinic — a consultation with Dr. Ashish Soni at Metro IVF in Ambikapur is the right next step.
The investigation that determines what is actually possible has not happened until it has been performed by a specialist with the clinical depth to perform it correctly.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
No sperm in the ejaculate is not the same as no sperm in the body. Book your consultation with Dr. Ashish Soni at Metro IVF today — and find out what is actually possible.